C. Villarroel

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator

I. Psallidas, C. Astbury, B. Seoane, 2020, Respiratory Research.

A randomized placebo and active controlled trial of AZD8871 a novel dual acting bronchodilator in COPD patients

Dave Singh, C. Astbury, B. Seoane, 2017 .

A randomized placebo controlled trial of AZD8871 a novel dual acting bronchodilator in asthmatics

C. Astbury, B. Seoane, M. Albayaty, 2017 .

Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator

Dave Singh, I. Psallidas, C. Astbury, 2020, Respiratory Research.